{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T17:18:40Z","timestamp":1776878320388,"version":"3.51.2"},"reference-count":16,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["mcpiqojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings: Innovations, Quality &amp; Outcomes"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.mayocpiqo.2022.06.004","type":"journal-article","created":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T05:20:14Z","timestamp":1657171214000},"page":"409-419","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Pitfalls of Mining for QuantiFERON Gold in Severely Ill Patients With COVID-19"],"prefix":"10.1016","volume":"6","author":[{"given":"Melissa P.","family":"Cortes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carrie S.","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahin","family":"Isha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge E.","family":"Sinclair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivang","family":"Bhakta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie L.","family":"Kunze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick W.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer B.","family":"Cowart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rickey E.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo Moreno","family":"Franco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devang K.","family":"Sanghavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Archana","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mayocpiqo.2022.06.004_bib1","series-title":"Clinical Spectrum of SARS-CoV-2 Infection","year":"2021"},{"issue":"8","key":"10.1016\/j.mayocpiqo.2022.06.004_bib2","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1016\/j.mayocpiqo.2022.06.004_bib3","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.2020.17021","article-title":"Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial","volume":"324","author":"Tomazini","year":"2020","journal-title":"JAMA"},{"issue":"16","key":"10.1016\/j.mayocpiqo.2022.06.004_bib4","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1056\/NEJMoa2100433","article-title":"Interleukin-6 receptor antagonists in critically ill patients with Covid-19","volume":"384","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.mayocpiqo.2022.06.004_bib5","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.3390\/ijms22073773","article-title":"Corticosteroids for COVID-19 therapy: potential implications on tuberculosis","volume":"22","author":"Gopalaswamy","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"3-4","key":"10.1016\/j.mayocpiqo.2022.06.004_bib15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.14745\/ccdr.v43i34a01","article-title":"Latent tuberculosis infection: an overview","volume":"43","author":"Kiazyk","year":"2017","journal-title":"Can Commun Dis Rep"},{"issue":"5","key":"10.1016\/j.mayocpiqo.2022.06.004_bib6","first-page":"918","article-title":"Clinical significance of indeterminate QuantiFERON-TB gold plus assay results in hospitalized COVID-19 patients with severe hyperinflammatory syndrome","volume":"10","author":"Solanich","year":"2021","journal-title":"J\u00a0Clin Med"},{"issue":"2","key":"10.1016\/j.mayocpiqo.2022.06.004_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/cid\/ciw778","article-title":"Official American Thoracic Society\/Infectious Diseases Society of America\/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children","volume":"64","author":"Lewinsohn","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.mayocpiqo.2022.06.004_bib8","doi-asserted-by":"crossref","first-page":"e00811","DOI":"10.1128\/JCM.00811-21","article-title":"Indeterminate QuantiFERON Gold Plus results reveal deficient interferon gamma responses in severely ill COVID-19 patients","volume":"59","author":"Ward","year":"2021","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.mayocpiqo.2022.06.004_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.106204","article-title":"Preliminary observations on IGRA testing for TB infection in patients with severe COVID-19 eligible for immunosuppressive therapy","volume":"175","author":"Torre","year":"2020","journal-title":"Respir Med"},{"key":"10.1016\/j.mayocpiqo.2022.06.004_bib10","series-title":"ELISA. Package insert","year":"2019"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2022.06.004_bib11","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/bioinformatics\/btr597","article-title":"MissForest\u2014non-parametric missing value imputation for mixed-type data","volume":"28","author":"Stekhoven","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.mayocpiqo.2022.06.004_bib22","series-title":"9.6 SHAP (SHapley Additive exPlanations). Interpretable Machine Learning","author":"Molnar","year":"2022"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2022.06.004_bib13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/07853890.2020.1828616","article-title":"External validation of a clinical risk score to predict hospital admission and in-hospital mortality in COVID-19 patients","volume":"53","author":"Halalau","year":"2021","journal-title":"Ann Med"},{"issue":"2","key":"10.1016\/j.mayocpiqo.2022.06.004_bib12","first-page":"244","article-title":"In patients with severe COVID-19, the profound decrease in the peripheral blood T-cell subsets is correlated with an increase of QuantiFERON-TB Gold Plus indeterminate rates and reflecting a reduced interferon-gamma production","volume":"12","author":"Imeneo","year":"2022","journal-title":"Life (Basel)"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2022.06.004_bib14","first-page":"1","article-title":"Effects of acute critical illnesses on the performance of interferon-gamma release assay","volume":"6","author":"Huang","year":"2016","journal-title":"Sci Rep"}],"container-title":["Mayo Clinic Proceedings: Innovations, Quality &amp; Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542454822000455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542454822000455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T19:33:29Z","timestamp":1722972809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2542454822000455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S2542454822000455"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocpiqo.2022.06.004","relation":{},"ISSN":["2542-4548"],"issn-type":[{"value":"2542-4548","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Pitfalls of Mining for QuantiFERON Gold in Severely Ill Patients With COVID-19","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings: Innovations, Quality & Outcomes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocpiqo.2022.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc on behalf of Mayo Foundation for Medical Education and Research.","name":"copyright","label":"Copyright"}]}}